Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy. (2022). Farmeconomia. Health Economics and Therapeutic Pathways, 23(1). https://doi.org/10.7175/fe.v23i1.1510